Related Articles by Review for PMID: 24217510

Year	Number of Results
2003	2
2004	2
2009	3
2010	3
2011	1
2012	4
2013	3
2014	10
2015	3
2016	3
2017	3
2018	7
2019	7
2020	11
2021	5
2022	5
2023	2
2024	0

1

Alzheimer disease therapy--moving from amyloid-β to tau.

Giacobini E, Gold G. Giacobini E, et al. Nat Rev Neurol. 2013 Dec;9(12):677-86. doi: 10.1038/nrneurol.2013.223. Epub 2013 Nov 12. Nat Rev Neurol. 2013. PMID: 24217510 Review.

2

Tau-based therapeutic approaches for Alzheimer's disease - a mini-review.

Boutajangout A, Wisniewski T. Boutajangout A, et al. Gerontology. 2014;60(5):381-5. doi: 10.1159/000358875. Epub 2014 Apr 8. Gerontology. 2014. PMID: 24732638 Free PMC article. Review.

3

Immunotherapy for Alzheimer's disease.

Wang W, Fan L, Xu D, Wen Z, Yu R, Ma Q. Wang W, et al. Acta Biochim Biophys Sin (Shanghai). 2012 Oct;44(10):807-14. doi: 10.1093/abbs/gms065. Epub 2012 Aug 16. Acta Biochim Biophys Sin (Shanghai). 2012. PMID: 22899646 Free article. Review.

4

Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.

Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A. Panza F, et al. Immunotherapy. 2012 Feb;4(2):213-38. doi: 10.2217/imt.11.170. Immunotherapy. 2012. PMID: 22339463 Review.

5

Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.

Gulisano W, Maugeri D, Baltrons MA, Fà M, Amato A, Palmeri A, D'Adamio L, Grassi C, Devanand DP, Honig LS, Puzzo D, Arancio O. Gulisano W, et al. J Alzheimers Dis. 2018;64(s1):S611-S631. doi: 10.3233/JAD-179935. J Alzheimers Dis. 2018. PMID: 29865055 Free PMC article. Review.

6

Tau Biology and Tau-Directed Therapies for Alzheimer's Disease.

Bakota L, Brandt R. Bakota L, et al. Drugs. 2016 Mar;76(3):301-13. doi: 10.1007/s40265-015-0529-0. Drugs. 2016. PMID: 26729186 Free PMC article. Review.

7

Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

Bloom GS. Bloom GS. JAMA Neurol. 2014 Apr;71(4):505-8. doi: 10.1001/jamaneurol.2013.5847. JAMA Neurol. 2014. PMID: 24493463 Review.

8

Amyloid-β-independent regulators of tau pathology in Alzheimer disease.

van der Kant R, Goldstein LSB, Ossenkoppele R. van der Kant R, et al. Nat Rev Neurosci. 2020 Jan;21(1):21-35. doi: 10.1038/s41583-019-0240-3. Epub 2019 Nov 28. Nat Rev Neurosci. 2020. PMID: 31780819 Review.

9

Beyond the neurotransmitter-focused approach in treating Alzheimer's disease: drugs targeting beta-amyloid and tau protein.

Panza F, Solfrizzi V, Frisardi V, Imbimbo BP, Capurso C, D'Introno A, Colacicco AM, Seripa D, Vendemiale G, Capurso A, Pilotto A. Panza F, et al. Aging Clin Exp Res. 2009 Dec;21(6):386-406. doi: 10.1007/BF03327445. Aging Clin Exp Res. 2009. PMID: 20154508 Review.

10

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Long JM, Holtzman DM. Long JM, et al. Cell. 2019 Oct 3;179(2):312-339. doi: 10.1016/j.cell.2019.09.001. Epub 2019 Sep 26. Cell. 2019. PMID: 31564456 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

66 results

Results by year